Premaitha Share Discussion Threads

[elrico] 14/2/2017 14:07

I don't believe it has been oversold. There are obvious concerns surrounding Illumina. Markets don't like uncertainty. Once this uncertainty has been cleared there will be a buzz about NIPT.

[hamidahamida] 14/2/2017 13:25

Oversold by a mile

[thinkbig?] 14/2/2017 13:23

Well that's an interesting purchase. I would say it's A good sign first in a long while.This stock is slowly going into positive thinking now for investors. It's losing all the negativity. It has had over the past few years.

[timojelly] 14/2/2017 10:51

Cleared overhang? Who knows

[hjb1] 13/2/2017 23:34

I think it's out there that they don't expect a win or lose binary situation.I expect there will be a licence granted or some sort of agreement before it gets to court.It would certainly help if the EU lot found in favour of Prem, then again that'll take bloody ages I expect, probably after July anyway.I believe Prem have evidence of anti trust/competition behaviour by Illumina so plenty of ammo I hope.

[elrico] 13/2/2017 23:18

You never can tell where lawyers are work, anything is possible. I have been doing a lot of research on IP, patents and trademarks concerning another of my investments and gained a great insight into the brinksmanship, patent trolling & strategies these cases exhibit. Illumina comes under the category of patent troll, a strategy rife in the USA. Shock horror! Illumina has a habit of losing and I expect it to do so here. However, I wouldn't rule out an OOCS. I would rather NIPT win outright and go after Illumina's market and stick it to them. I hate bullies with a passion.

[hjb1] 13/2/2017 22:34

not sure if peeps have seen this before, it is the reply from the good DR at Hardman's who was asked about the patents validity etc. and especially note the part that says it's possible to circumvent the patents. He is responsible for the research into Prem I believe;

Dear Mr .....
First, I have undertaken a complete review of the patent situation in Europe and came to the conclusion that Illumina has a very weak case. However, I have not been allowed to publish this work because the lawyers stated that I had supplied the entire defense and did not want this in the public domain. So I think that Premaitha has a good chance of winning its case. However, I am also aware of time and costs and could understand a situation where Premaitha settles out of court on the right terms - ie close to the royalty rate that is paid by its 'friends' as opposed to the $75 per test that Illumina wants to charge Great Ormond Street Hospital.

Notwithstanding this, Illumina's patents are not covered in several territories in SE Asia. This provides two things. First, it means that IONA can be used in these markets without risk of patent infringement. Secondly, it means that maternal blood samples can be spun down and analysed in, say Europe, and the results sent to Taiwan for analysis (as Yourgene is currently doing), thus avoiding Illumina's European patents. Therefore, I feel that this is a realistic possibility in the unlikely event that the Illumina patents are upheld.

I hope that this helps.

Dr.......
Life Sciences Team

[andrewsr] 13/2/2017 22:19

Raising cash would hardly be a problem if the cash burn is rapidly narrowing and expected to be cash flow positive in the next year or 2. If they have a successful product with multi-billion pound potential then raising cash/debt or a placing would probably be sorted without any effect on the share price. The litigation seems more of a concern though.
I'm not invested here but it looks compelling if they can shake off Illumina.

[michaelmouse] 13/2/2017 17:29

Of course you wouldn't even dare contemplate Illuminia winning their litigation would you? I hope you've not opened a spread bet again elrico. Churchill Mining must still be fresh in your memory, and no stop losses are honoured with a 7am wipe out.

It makes you shudder just thinking about it.

[michaelmouse] 13/2/2017 17:24

Your maths isn't very good elrico, but at least you've had a go. Well done, but incorrect. You can't just add £2.7m cash at September year end to the additional £4m debt they've taken on.

Firstly, there's a little matter of something called cashburn. Have you heard of this?

In fact, in the six months to September they burned £4.2m. That's about £700,000 per month. Even if they've reduced cash burn (and I haven't any reason to believe it's reduced by very much) let's be generous and assume since September they've burned another £2.5m. That wipes out their cash.

You've also missed the existing debt which stood at £2.6m of which approx. £680,000 is still left for drawdown, although of course this will be gone soon.

In short they may have around £4m of debt left to draw upon. That will be gone in 8 months. That's not long. What then?

A company with no cash left, very little revenue, cashflow positive 12/18 months away at best and £6.8m of debt with interest payable at 6%.

I could tell you the most likely scenario but I'll leave you to work it out. After all you're a financial whizz and I can't really articulate my case. ;)

[elrico] 13/2/2017 16:58

Michaelmouse is not known for his analytical skills...allow me to help you, good sir. As of December, NIPT by my maths had c£6.7m available funding and will increased sales as announced, the cashburn will no doubt be reduced further. If funding is required, it is some way off and will most likely after the illumina debacle to ramp up commercial activities in territories illumina have tried to stop because they know NIPT have a far superior product, and sort of gets in the way of illumina's attempt to dominate the world with its product. Question is....do illumina rollover or buy NIPT?

Cash call is a strategy you use a lot as we have seen on the OPTI thread. You were wrong then and most likely wrong now. You even got the stated cash in bank figure wrong, several time and even after other posts corrected you, you continued with your lies. That is your strategy, lies, lies and more lies.

If I were you I would spend more time performing DD on your next disaster rather than troll me. You look a rank amatuer and now you have to resort to childish name calling because you can't articulate your case.

edit for grammar police. It's a BB FFS not a broker note.

[michaelmouse] 13/2/2017 16:53

twix386 - It'll be interesting to see how the next cash call is funded? They need cash that's for sure. Let's wait and see shall we.

[hjb1] 13/2/2017 16:44

ooooh! looks like I wind you up too..ha ha, HILARIOUS!, love it.As your Disney name suggests you are in FANTASYLAND pal, Elrico has outed you as the troll you are...jog on!

[twix386] 13/2/2017 16:38

Sure and in the real world nobody expects a funding down at 5p either, which was your take.

[michaelmouse] 13/2/2017 16:22

If you say so looksdead. In the real world I just state how it is, and then watch and wait. ;)

[hjb1] 13/2/2017 16:14

hey Mickey, can you tell us something we don't know!, talk about stating the bleedin' obvious..oh! and it sounds like elrico really DOES get under your skin..lmao!

[philburt] 13/2/2017 11:37

Micky Mouse advisor filtered....

[twix386] 13/2/2017 11:28

I see elrico.That explains a lot and it was already clear he was here to bash. Thanks

[michaelmouse] 13/2/2017 10:02

The share price will then follow it down in due course imo.

[michaelmouse] 13/2/2017 10:01

When the fund raising comes, I'd expect around the recent low of 5p imo.